TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules
Andrew C. McShan, Christine A. Devlin, Georgia Papadaki, Yi Sun, Adam I. Green, Giora I. Morozov, George M. Burslem, Erik Procko, Nikolaos G. Sgourakis
Topics & Concepts
Chaperone (clinical)Docking (animal)Cell biologyLigand (biochemistry)ChemistryBiophysicsSmall moleculeChemical chaperonePlasma protein bindingMajor histocompatibility complexBiochemistryBiologyEndoplasmic reticulumReceptorUnfolded protein responsePathologyNursingGeneMedicineHepatitis B Virus StudiesProtein purification and stabilityDrug Transport and Resistance Mechanisms